TFX [NYSE]
Teleflex Incorporated
IndexS&P 500 P/E24.63 EPS (ttm)10.28 Insider Own0.20% Shs Outstand46.88M Perf Week1.67%
Market Cap11.58B Forward P/E16.54 EPS next Y15.31 Insider Trans-11.60% Shs Float46.80M Perf Month-11.28%
Income487.60M PEG2.37 EPS next Q3.34 Inst Own99.70% Short Float2.56% Perf Quarter-26.58%
Sales2.82B P/S4.11 EPS this Y44.00% Inst Trans-0.65% Short Ratio3.34 Perf Half Y-23.52%
Book/sh80.97 P/B3.13 EPS next Y9.59% ROA7.00% Target Price352.80 Perf Year-37.68%
Cash/sh10.21 P/C24.81 EPS next 5Y10.40% ROE13.30% 52W Range244.81 - 428.36 Perf YTD-22.90%
Dividend1.36 P/FCF24.43 EPS past 5Y15.50% ROI9.60% 52W High-40.88% Beta1.15
Dividend %0.54% Quick Ratio1.50 Sales past 5Y8.50% Gross Margin55.10% 52W Low3.45% ATR7.53
Employees14000 Current Ratio2.30 Sales Q/Q1.20% Oper. Margin21.80% RSI (14)38.38 Volatility2.65% 2.53%
OptionableYes Debt/Eq0.49 EPS Q/Q3.40% Profit Margin17.30% Rel Volume1.19 Prev Close259.56
ShortableYes LT Debt/Eq0.46 EarningsApr 28 BMO Payout13.10% Avg Volume358.32K Price253.26
Recom2.40 SMA20-5.37% SMA50-10.98% SMA200-22.38% Volume427,677 Change-2.43%
May-09-22Initiated BofA Securities Neutral $315
Apr-13-22Initiated Truist Hold $370
Jan-07-22Downgrade Morgan Stanley Overweight → Equal-Weight $431 → $383
Jan-04-22Downgrade Piper Sandler Overweight → Neutral $465 → $325
Dec-10-21Initiated RBC Capital Mkts Outperform $415
Oct-07-21Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Sep-07-21Resumed Raymond James Outperform $440
Jul-19-21Downgrade SVB Leerink Outperform → Mkt Perform $410
Jan-06-21Reiterated Needham Buy $406 → $445
Nov-02-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $382
Jan-31-20Reiterated Needham Buy $408 → $423
Aug-02-19Reiterated Needham Buy $325 → $403
Jun-11-19Initiated Wells Fargo Outperform $345
Apr-24-19Downgrade Needham Strong Buy → Buy $325
Feb-22-19Reiterated Needham Strong Buy $300 → $325
Oct-16-18Initiated Barclays Equal Weight $266
Sep-10-18Upgrade Needham Buy → Strong Buy $279 → $300
Aug-03-18Reiterated Needham Buy $298 → $279
May-14-18Reiterated Needham Buy $293 → $298
May-04-18Reiterated Needham Buy $285 → $293
Jun-23-22 07:56AM  
Jun-22-22 06:30AM  
Jun-14-22 10:53AM  
Jun-13-22 04:30PM  
Jun-09-22 11:30AM  
Jun-07-22 12:30AM  
Jun-03-22 11:31AM  
Jun-01-22 06:30AM  
May-31-22 07:13AM  
May-23-22 02:48PM  
May-20-22 06:30AM  
May-19-22 06:30AM  
May-18-22 06:30AM  
May-17-22 11:02AM  
May-16-22 08:30AM  
May-13-22 06:30AM  
May-03-22 08:05AM  
May-02-22 08:37AM  
06:45AM  
06:30AM  
Apr-29-22 11:02AM  
10:30AM  
Apr-28-22 07:55AM  
06:30AM  
Apr-27-22 11:49AM  
Apr-26-22 06:45AM  
06:30AM  
Apr-21-22 03:01PM  
Apr-18-22 10:13AM  
Apr-14-22 06:30AM  
Apr-11-22 06:30AM  
Apr-05-22 10:05AM  
Mar-25-22 07:50PM  
Mar-11-22 09:14AM  
Mar-10-22 12:48PM  
12:17PM  
Mar-09-22 06:30AM  
Mar-03-22 06:07AM  
Mar-02-22 06:30AM  
Feb-25-22 08:47AM  
Feb-24-22 07:45AM  
06:45AM  
06:30AM  
Feb-23-22 06:30AM  
Feb-17-22 03:03PM  
Feb-10-22 06:30AM  
Feb-08-22 05:55PM  
01:56PM  
09:38AM  
Feb-07-22 05:38PM  
Jan-19-22 01:38PM  
Jan-18-22 08:33AM  
Jan-14-22 09:27AM  
Jan-13-22 03:38PM  
Jan-12-22 05:38PM  
Jan-04-22 06:30AM  
Dec-29-21 05:48PM  
Dec-22-21 09:25AM  
Dec-19-21 05:38AM  
Dec-18-21 08:38PM  
Dec-14-21 11:13AM  
Dec-13-21 03:38PM  
06:30AM  
Dec-11-21 10:26PM  
05:38AM  
Nov-29-21 11:17AM  
Nov-26-21 06:00PM  
Nov-18-21 06:45AM  
06:30AM  
Nov-15-21 08:52AM  
Nov-04-21 06:30AM  
Nov-03-21 03:02PM  
06:48AM  
Oct-29-21 10:24AM  
06:30AM  
Oct-28-21 05:00PM  
08:35AM  
06:45AM  
06:30AM  
Oct-27-21 06:30AM  
Oct-21-21 03:03PM  
Oct-18-21 05:18AM  
Oct-14-21 06:30AM  
Sep-28-21 01:20PM  
Sep-14-21 06:30AM  
Sep-13-21 08:17AM  
Sep-09-21 06:30AM  
Sep-01-21 06:30AM  
Aug-30-21 06:30AM  
Aug-26-21 11:21AM  
06:30AM  
Aug-17-21 10:13AM  
Jul-30-21 10:28AM  
Jul-29-21 08:02PM  
07:45AM  
06:45AM  
06:30AM  
Jul-22-21 03:03PM  
Jul-19-21 08:21AM  
07:09AM  
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RANDLE STUART ADirectorJun 07Option Exercise78.503,014236,5997,334Jun 09 05:33 PM
RANDLE STUART ADirectorJun 07Sale283.313,014853,8964,320Jun 09 05:33 PM
Kelly LiamChairman, President & CEODec 27Option Exercise59.918,987538,38334,762Dec 29 04:37 PM
Kelly LiamChairman, President & CEODec 27Sale330.008,9872,965,71025,775Dec 29 04:37 PM
Krakauer Andrew ADirectorNov 30Buy307.231,000307,2323,534Dec 02 04:57 PM
Hicks Cameron PCorp. VP & Chief HR OfficerNov 10Option Exercise121.003,600435,60012,204Nov 12 04:36 PM
Hicks Cameron PCorp. VP & Chief HR OfficerNov 10Sale350.003,6001,260,0008,604Nov 12 04:36 PM
Kelly LiamChairman, President & CEOAug 18Option Exercise59.758,987536,97334,762Aug 20 04:46 PM
Kelly LiamChairman, President & CEOAug 18Sale376.328,9873,381,97325,775Aug 20 04:46 PM
Klasko Stephen K. M.D.DirectorJul 12Option Exercise59.753,564212,9494,988Jul 13 09:12 PM
Klasko Stephen K. M.D.DirectorJul 12Sale422.553,5641,505,9681,424Jul 13 09:12 PM